Benzinga - by Lisa Levin, Benzinga Editor.
Henry Schein Inc (NASDAQ: HSIC) posted downbeat sales results for its third quarter on Monday.
Henry Schein reported quarterly sales of $3.16 billion, slightly missing the consensus of $3.21 billion. Adjusted EPS of $1.32, up 2.3% Y/Y, in line with the estimate.
Henry Schein updated its FY23 adjusted EPS guidance to $4.43-$4.71, reflecting a narrowing of the previous guidance range for the underlying business to $5.18-$5.26 from its previous guidance of $5.18-$5.35, reflecting softening macroeconomic conditions.
Henry Schein gained 1.5% to trade at $68.54 on Tuesday.
These analysts made changes to their price targets on Henry Schein following earnings announcement.
- Morgan Stanley cut the price target on Henry Schein from $69 to $65. Morgan Stanley analyst Erin Wright maintained an Underweight rating.
- Barrington Research slashed the price target on Henry Schein from $90 to $82. Barrington Research analyst Michael Petusky maintained an Outperform rating.
- UBS lowered the price target on Henry Schein from $82 to $75. UBS analyst Kevin Caliendo maintained a Neutral rating.
Latest Ratings for HSIC
Feb 2022 | Morgan Stanley | Maintains | Underweight | |
Feb 2022 | Credit Suisse | Maintains | Outperform | |
Jan 2022 | Morgan Stanley | Initiates Coverage On | Underweight |
View the Latest Analyst Ratings
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.